Measurement of EBV Specific Cytotoxic T Cells (EBV-Tc) in Renal Transplant Patients (Tx Pts).

被引：0
|
作者：
Jinadu, Laide [1 ]
Ge, Shili [1 ]
Pao, Andy [1 ]
Kamil, Elaine [1 ]
Jordan, Stanley C. [1 ]
Puliyanda, Dechu [1 ]
Toyoda, Mieko [1 ]
机构：
[1] Cedars Sinai Med Ctr, Transplant Immunol Lab, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：715 / 715
页数：1
相关论文
共 50 条
  • [1] EBV-SPECIFIC T-CELL (EBVTc) ACTIVITY IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS (TX PTS) WITH AND WITHOUT EBV VIREMIA
    Puliyanda, Dechu P.
    Ge, Shili
    Karasyov, Artur
    Petroysan, Anna
    Jordan, Stanley C.
    Kamil, Elaine S.
    Toyoda, Mieko
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 94 - 94
  • [2] EBV Viremia and Development of EBV Specific Cytotoxic T-cells in Pediatric Renal Transplant Recipients.
    Pizzo, H.
    Puliyanda, D.
    Shin, B.
    Toyoda, M.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 978 - 978
  • [3] Adoptive Treatment Of EBV-Associated Leiomyosarcoma In Immunodeficient Patients With EBV Specific Cytotoxic T Cells
    Prockop, Susan E.
    Doubrovina, Ekaterina
    Boulad, Farid
    Kernan, Nancy A.
    Kobos, Rachel
    Scaradavou, Andromachi
    Abramson, Sara J.
    Laquaglia, Michael
    Price, Anita
    O'Reilly, Richard J.
    BLOOD, 2013, 122 (21)
  • [4] HIGH LEVELS OF PLASMA IL-21 WITH EBV-SPECIFIC CYTOTOXIC T CELLS (EBVTC) MAY CONTRIBUTE TO AVOIDANCE OF POST-TRANSPLANT (TX) LYMPHOPROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC KIDNEY TX PATIENTS (PTS) WITH PERSISTENT EBV VIREMIA (PEBV)
    Puliyanda, Dechu P.
    Ge, Shili
    Watanabe, Junji
    Karasyov, Artur
    Kamil, Elaine
    Lovato, Darly
    Rockymore, Monette
    Vikman, Susanna
    Jordan, Stanley
    Toyoda, Mieko
    PEDIATRIC TRANSPLANTATION, 2013, 17 : 53 - 53
  • [5] Treatment of EBV plus nasopharyngeal carcinoma with banked EBV-specific cytotoxic T cells
    Prockop, Susan
    Doubrovina, Ekatarina
    Baxi, Shrujal S.
    Escobedo, Virginia
    Suser, Stephanie
    Szenes, Victoria
    Pfister, David G.
    O'Reilly, Richard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Expansion of EBV and CMV specific cytotoxic T-cells
    Holter, W
    Ressmann, G
    Lehner, M
    Felzmann, T
    Buchberger, M
    Clodi, K
    Wimmer, D
    Gadner, H
    Popow, T
    BONE MARROW TRANSPLANTATION, 2001, 27 : S139 - S139
  • [7] Autologous EBV-specific cytotoxic T cells to treat EBV-associated post-transplant lymphoproliferative disease (PTLD).
    Comoli, P
    Locatelli, F
    Gerna, G
    Grossi, P
    Vigano, M
    Maccario, R
    BLOOD, 1997, 90 (10) : 1097 - 1097
  • [8] High Levels of Plasma IL-21 Together with EBV-Specific Cytotoxic T Cells (EBVTc) May Contribute Avoidance to Post-Transplant (Tx) Lymphoroliferative Disorder (PTLD) in Pediatric Kidney Tx Patients (pts) Who Had Persistent EBV Infection (PEBV)
    Ge, S.
    Puliyanda, D.
    Junji, W.
    Karasyov, A.
    Kamil, E.
    Lovato, D.
    Monette, R.
    Vikman, S.
    Jordan, S.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 287 - 287
  • [9] EFFECT OF INHALED CORTICOSTEROIDS ON EBV-SPECIFIC CYTOTOXIC T-CELLS AND EBV OROPHARYNGEAL EXCRETION
    ABO, W
    IMAI, S
    SUGIURA, M
    TERAI, N
    OSATO, T
    SHIMANO, Y
    CHIBA, S
    LANCET, 1992, 340 (8819): : 606 - 606
  • [10] Genetically modified EBV-specific cytotoxic T cells for adoptive transfer to patients with EBV-positive Hodgkin disease.
    Roskrow, MA
    Suzuki, N
    Heslop, HE
    Hudson, M
    Brenner, MK
    Rooney, CM
    BLOOD, 1996, 88 (10) : 2679 - 2679
12345